492: Improving vaccines: Immunogenicity and safety
The expected results from our studies will inform vaccine design against HIV and other infectious agents, potentially leading to clinical trials in man. Moreover we expect to achieve a greater understanding of unwanted, potentially dangerous vaccine effects, so that we can avoid them.
Date: Tue Aug 29 14:18:16 BST 2006
